GlassScriptPhysician profile
Jean E Schneider
NPI 1679836589
$1,659.61
in general payments reported to CMS, 2019-2025
12 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.41 · 2020: $33.22 · 2021: $109 · 2022: $139 · 2023: $160 · 2024: $748 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $427.41 | 2023-2025 | Biktarvy |
| Viiv Healthcare Company | $407.31 | 2023-2025 | Dovato, Rukobia, Cabenuva |
| Merck Sharp & Dohme LLC | $249.43 | 2023-2025 | Pifeltro, Delstrigo |
| Novo Nordisk INC | $162.72 | 2020-2022 | |
| Abbvie INC. | $93.70 | 2023-2025 | Mavyret |
| Theratechnologies INC. | $89.14 | 2024-2025 | Egrifta, Trogarzo |
| Genentech, INC. | $65.59 | 2025 | Ocrevus |
| Glaxosmithkline, LLC. | $51.48 | 2019-2021 | |
| Abbott Laboratories | $47.99 | 2022 | |
| Indivior INC. | $29.08 | 2024 | Sublocade |
| Lilly USA, LLC | $18.46 | 2022 | |
| Emd Serono, INC. | $17.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.